Canadian Smoking Cessation Clinical Practice Guideline

CANADIAN SMOKING CESSATION GUIDELINEOVERVIEW OF EVIDENCEThe following recommendations, and supportingevidence, have been extracted from existing clinicalpractice guidelines to inform the development of the CAN-ADAPTT Summary Statements.• SPECIFICPOPULATIONS:Aboriginal Peoples †CAN-ADAPTT’s Clinical PracticeGuideline Development Group;Section Lead: Sheila Cote-Meek,BScN, MBA, PhDCAN-ADAPTT worked with the Guidelines AdvisoryCommittee (GAC) to conduct a literature search(years: 2002-2009) to identify existing clinical practiceguidelines (CPGs). Five existing clinical practiceguidelines were identified as meeting the high qualitycriteria set out in the AGREE Instrument. Therecommendations contained in these high qualityCPGs have been used as the evidence base for theCAN-ADAPTT guideline development process.The strength of evidence classification for each ofthese existing CPGs can be found in Appendix F.Note that the grade of recommendation/strength ofevidence summary table for CAN-ADAPTT’ssummary statements can be found in Appendix B.New Zealand Ministry of Health (2007) 14Offer Ma¯ori who smoke cessation supportthat incorporates known effective components(such as medication). (Grade of Evidence = √)Where available, offer culturally appropriatecessation services to Ma¯ ori. (Grade ofEvidence = C)Health care workers should be familiar withthe cessation support services for Ma¯ ori thatare available in their area (such as localAukati Kai Paipa providers) and nationally(such as Quitline) so they can referappropriately.(Grade of Evidence = √)Health care workers providing cessationsupport to Ma¯ori should seek training inhow to deliver smoking cessation treatment toMa¯ ori. (Grade of Evidence = √)†Aboriginal peoples is used as an inclusive term whichincludes First Nations (both on and off reserve), Inuit, andMétis. This is not meant to take away from the diversity thatexists among Aboriginal peoplesABORIGINAL PEOPLES 16